Provided by Tiger Trade Technology Pte. Ltd.

Personalis

18.38
+1.508.89%
Post-market: 18.470.0876+0.48%19:55 EDT
Volume:8.00M
Turnover:144.91M
Market Cap:1.97B
PE:-16.75
High:18.89
Open:16.66
Low:16.62
Close:16.88
52wk High:18.89
52wk Low:4.65
Shares:107.00M
Float Shares:72.63M
Volume Ratio:1.56
T/O Rate:11.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0976
EPS(LYR):-0.9107
ROE:-50.32%
ROA:-25.03%
PB:8.36
PE(LYR):-20.18

Loading ...

Personalis Secures Fourth Medicare Coverage Decision for Next Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monitoring

THOMSON REUTERS
·
May 20

Personalis Inc - Coverage NOW Includes Neoadjuvant Therapy Monitoring for Stage Ii-Iii Tnbc or Her2+ Breast Cancer

THOMSON REUTERS
·
May 20

Personalis Shareholders Back Directors, Auditor and Executive Pay

TIPRANKS
·
May 14

Personalis Gains Expanded Medicare Coverage for NeXT Personal

TIPRANKS
·
May 14

Personalis stockholders elect two Class I directors at annual meeting

Reuters
·
May 14

Sector Update: Healthcare Stocks Lean Lower Pre-Bell Wednesday

MT Newswires Live
·
May 13

BUZZ-U.S. STOCKS ON THE MOVE-Nebius, US chipmakers, Assertio Holdings

Reuters
·
May 13

BUZZ-U.S. STOCKS ON THE MOVE-Orla Mining, Personalis, Eos Energy

Reuters
·
May 13

Personalis Shares Rise on Medicare Coverage for Immunotherapy Monitoring

Dow Jones
·
May 13

Personalis Receives Medicare Coverage for Next Personal® for Immunotherapy Monitoring Across Late-Stage Solid Tumors

THOMSON REUTERS
·
May 13

Personalis wins expanded Medicare coverage for NeXT Personal immunotherapy monitoring test

Reuters
·
May 13

Personalis Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
May 13

Personalis price target lowered to $9 from $10 at Morgan Stanley

TIPRANKS
·
May 12

Analysts Are Bullish on These Healthcare Stocks: CVRx (CVRX), Personalis (PSNL)

TIPRANKS
·
May 12

Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (BNTX), Personalis (PSNL) and Alpha Tau Medical Ltd (DRTS)

TIPRANKS
·
May 12

Morgan Stanley Cuts Price Target on Personalis to $9 From $10, Keeps Equalweight Rating

MT Newswires Live
·
May 12

Personalis price target lowered to $11 from $13 at BTIG

TIPRANKS
·
May 11

Personalis Is Maintained at Buy by BTIG

Dow Jones
·
May 11

Personalis Inc Files for Mixed Shelf Offering; Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
May 08

Personalis Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08